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ABSTRACT 
 
Adipose tissue has an extracellular matrix (ECM) which is enriched in the fibrillar 
protein collagen, elastin, basement membrane protein laminin, Glycosaminoglycans, and 
proteoglycans. All the components have very important role in tissue development and 
function, hence applicable in tissue engineering and regenerative medicine. We decellularised 
the adipose tissue using the combination of 1) Physical methods such as blending and freeze-
thawing and the 2) chemical methods such as SDS. We found that the subsequent freeze dried 
decellularized adipose tissue results in highly porous scaffold of average pore size 257µm. 
We characterized the scaffold and found that it is suitable for soft tissue engineering 
applications but it is not suitable for bone tissue engineering because of its poor mechanical 
strength. To increase the mechanical strength, we prepared the composite of hydroxyapatite 
nanoparticle and ECM and characterized by FTIR and XRD. We prepared the 
Hydroxyapatite nanoparticle by wet chemical method and ECM-nano hydroxyapatite 
composite scaffold by the suspension method.  The scaffolds fabricated possess a porous 
structure with an average pore size of 170µm and with an improved mechanical strength 
which is suitable for bone tissue engineering.  
 
KEYWORDS:Extracellular matrix, Adipose derived stem cell, nanohydroxyapatite, bone 
tissue engineering  
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1. INTRODUCTION: 
 
1.1. Clinical Importance of Bone tissue engineering  
There are over 1 million Bone Graft replacements happening in a year in order to 
obtain Unions on defective bone cases. India‘s fractures caused by arthritis and osteoporosis 
are alarmingly increasing
 [1]
. According to census around Four hundred forty thousand 
Indians suffer from hip fractures, 26 hundred thousand suffer from osteoporosis and the same 
is expected to rise to 36 hundred thousand by fag end of 2013. Current diagnosis 
methodologies are majorly based on autologus bone crafts, autogeneous bone grafts or metal 
ceramics as an alternative approach 
[2-5]
. 
To give an idea of these concepts, as explained here under. 
• Autologous bone graft is a methodology in which a bone from another region of the 
patient body itself is used in the defective or fractured area and this has been the 
conventional method for decades. The commonly used bones for this methodology are 
the iliac crest that is taken in the form of trabecular bone and at times cortical bones 
are also used based on the cases
 [5, 7-8]
. It is interesting to note that, although this case 
sounds to be successful in majority of times, it has its own limitations due to the 
limited amount of autograft that can be obtained and also due to donor site morbidity 
[2-5]
. 
• Second methodology is the Allograft where a bone from another person‘s body is 
introduced into the recipient. However as it deals with two different bodies of 
different biological compositions, the rate of acceptance of new bone in the 
receipients body are much slower than the autologous method. In addition to this, 
there are also chances of immune rejection and pathogen transfer to the recipient body 
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thus causing a change in the immunological functioning of the recipient after 
transplantation 
[2-5]
. 
• As an alternative to the above methodologies, metal ceramics is brought in picture [2]. 
Looking at the advantageous section of this technique is that they give immediate 
mechanical support and rigidity. However as a major consequence this methodology 
exhibits poor overall integration with the tissue and as a result can fail due to infection 
due to fatigue loading 
[2]
. Also ceramics are of low tensile strength and cannot be used 
in locations which experience shear, high stress and bending. 
Hence it is clearly seen that an adequate bone replacement is yet to be found and it is at the 
same time urgently needed for full recovery of the patients. A possible solution for these 
problems may be in TE. 
1.2. Scaffolds used for tissue engineering: 
A new therapeutic technology called Tissue engineering is more aimed at repair and 
regeneration of damaged tissues and organs. It is a detailed process of seeding of allogenic 
cells on scaffold (biomaterial) and the tissue construct is planted on the damaged area. The 
biggest advantage is the fact that injected cells remain in architecture of scaffolds and so do 
not have unnecessary diffusion of cells as in Stem cell therapy. The heart of this technology 
called scaffolds should be non-toxic, non-immunogenic, non-immunogenic,  cytocompatible,  
biodegradable,  hydrophilic  and  highly  porous  and  it  should  have  mechanical  strength  
similar  to  that  of  target  tissue  or  organ  in  totality to mimic native microenvironment. 
The various scaffolding materials used in this area can be broadly classified as polymers, 
ceramics etc
 [10]
. 
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  The scaffolding materials using in tissue engineering can be divided in to polymers, 
ceramics and metallic as shown in fig 1 
 
Figure 2: Classification of materials used for scaffold fabrication 
Synthetic  polymers,  Ceramics  (Except  hydroxyapatite  HA)  and  metallic  scaffold  cannot  
mimic  body microenvironment  in  all  aspects.  But  the  combination  of these with  natural  
polymers  like  collagen,  elastin,  glycosaminoglycan (GAGs), etc can mimic native extra 
cellular matrix (ECM) in some extent. The usage of ECM as a scaffold material can mimic 
the native ECM completely with negligible immune rejection and they can support the seeded 
cells and direct the cell growth effectively. 
 
 
 
 
Materials used  
as scaffolds  
Polymers 
Natural 
Eg: Chotosan, Silk, 
gelatin, Collagen,etc 
 
Synthetic 
Eg: PLA, PLLA, PLGA, 
PGA, PVA etc 
 
Ceramic 
Eg: Bioactive glass, 
hydroxy apatite 
(HA),etc  
Matallic  
Eg: Copper, Alumina, 
Stainless steel, 
Titanium, etc 
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2. LITERATURE REVIEW 
2.1. Significance of ECM in tissue: 
Extra cellular matrix is an acellular component present around the cells. Fibers like collagen 
and elastin, proteoglycan, glycoproteins contribute to ECM 
[11]
. ECM gives mechanical 
support for the cells, helps in differentiation and development of cells in the tissue and also 
possesses a great role in signalling pathways. Each component of ECM possesses different 
functions, some of the components and their functions are tabulated below. 
Table 5:  Core proteins found in the extracellular matrix 
Extracellular 
Protein  
Function  Main Tissue 
Locations  
ref 
Collagen 
Type I 
• Type I collagen found rope-like structures in 
tendon, sheet-like structures in skin, and in 
bone it is reinforced with nHA. 
• It gives tensile strength for the tissues. 
bone, dermis, 
tendon, 
ligaments, 
cornea 
12-14 
Collagen 
Type II 
• provide  tensile  strength  and  confers  on 
cartilage  the  ability  to  resist  shearing  
forces 
• supports chondrocyte adhesion  and  may  
influence  the  differentiated  phenotype  of 
these cells 
cartilage, 
vitreous body, 
nucleus 
pulposus and 
inter-vertebral 
disc  
12, 13 
Collagen 
Type III 
• essential for type I collagen fibrillogenesis 
during normal development of  the 
cardiovascular system and other organs  
Skin, vessel 
wall, reticular 
fibres of most 
tissues (lungs, 
liver, spleen, 
etc.) 
15, 16 
Collagen 
Type IV 
• The assembled type IV collagen meshwork 
provides a scaffold for the assembly of  other 
basement membrane components through 
basement  
membranes 
17, 18 
12 
 
specific interactions with laminin,  
entactinlnidogen and  heparan  sulphate 
proteoglycan 
• this meshwork endows the basement 
membrane with a size-selective filtration 
property. 
Collagen 
Type V 
• forms  heterotypic  fibrils  with  type  I  or  
types  I  and  III  collagens and help to provide 
mechanical strength for tissues.  
bone,  tendon,  
cornea,  
skin,  blood  
vessels  and  the  
more  compliant  
tissues,  liver,  
lung  and  
placenta. 
19, 16 
Collagen 
Type VI 
• roles in tissue organization and remodeling widespread: 
dermis, 
cartilage, 
placenta, lungs, 
vessel wall, 
intervertebral 
disc 
20-22 
Collagen 
Type VII 
• major component  of  anchoring fibrils 
• Anchor the basement membrane to the 
underlying stromal tissue. 
epidermis  and  
intestinal  sub-
mucosa 
23 
Collagen 
Type VIII 
• serve as a molecular bridge between different 
types of matrix molecules 
• In different tissues this collagen type may 
serve different functions. Stabilization of 
membranes, angiogenesis, and interactions 
with other extracellular matrix molecules. 
Descemet's  
membrane  
endothelial cells 
24, 25 
Collagen 
Type IX 
• participates in the formation of,  type II 
collagen  fibrils 
• linking type II collagen molecules 
cartilage,  
cornea , 
intervertebral  
16, 
26, 27 
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• serve to bridge collagen fibrils with other 
matrix macromolecules 
disc  and  
vitreous  
humour 
Collagen 
Type X   
• Involved in the process of mineralization, 
endochondral ossification, and is also 
proposed to play a role in angiogenesis. 
Calcifying 
cartilage 
25, 28 
Collagen 
Type XI 
• forms heterotypic fibrils with  types II  and IX 
collagens 
Cartilage, inter-  
vertebral disc 
and vitreous 
body 
29 
Collagen 
Type XII 
• modulate biomechanical properties of tissue Skin, tendon, 
ligaments  and 
cartilage 
16 
Collagen 
Type XIII 
• transmembrane component of  focal adhesion 
sites 
epidermis, hair 
follicle, 
endomysium, 
intestine, 
chondrocytes, 
lungs, liver, 
placenta, bone, 
and striated 
muscle 
16 
Collagen 
Type XIV 
• found in region where high mechanical 
stresses are involved  
dermis, tendon, 
vessel wall, 
placenta, lungs, 
liver  and 
cartilage 
30 
Collagen 
Type XV 
• Function to adhere basement membranes to 
underlying connective tissue stroma. Mouse 
studies have shown that collagen XV 
deficiency is associated with muscle and 
microvessel deterioration 
fibroblasts, 
smooth muscle 
cells, kidney, 
pancreas 
16 
Collagen • To maintain the integrity of the extracellular Heart, kidney,  31, 32 
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Type XVI matrix. intestine, ovary,  
testis,  eye,  
arterial walls 
and smooth 
muscles. 
Collagen 
Type XVII 
• role in maintaining the linkage between the 
intracellular and the extracellular structural 
elements involved in epidermal adhesion 
Hemidesmosom
es of specialized 
epithelia and 
dermal– 
epidermal 
junctions 
16 
Collagen 
Type XVIII 
• a potent antiangiogenic protein Kidney, liver, 
lung 
33 
Collagen XIX  • To maintain the integrity of the extracellular 
matrix. 
human 
rhabdomyosarco
ma 
34 
Elastin • provide  elasticity  and  resilience  to  tissues 
• Elastin promotes cell adhesion and elastin 
peptides have been shown to be chemotactic. 
Arteries, lungs, 
elastic 
ligaments, the 
skin, and the 
bladder, elastic 
cartilage. 
35 
Laminins 
(large 
glycoproteins
) 
• roles in development, differentiation and 
migration through their ability to interact with  
cells via  cell-surface receptors,  and with  
other basement  membrane  components  such  
as  type  IV  collagen,  entactinlnidogen  and 
heparan sulphate proteoglycan cell attachment 
and neurite outgrowth promotion. 
basal lamina 
foundation for 
most cells and 
organs 
36 
Fibrillin-1  
(glycoprotein
) 
• provide  the scaffold on to which elastin is  
assembled to form elastic fibers 
• functional role in non-elastic tissues is unclear 
Connective 
tissues. 
37 
Fibrillin-2 • Play a role in early elastogenesis. Connective 38 
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(glycoprotein
) 
tissues. 
Fibromodulin 
(small  
chondroitin  
sulphatelder
matan  
sulphate 
proteoglycan) 
• to  modulate  collagen fibre formation 
• fibromodulin binds types I and II collagen 
fibrils in vitro and inhibits collagen fibril 
assembly. 
Cartilage, 
tendon,  skin,  
sclera  and  
cornea 
39 
Link  protein • binds  to  both  cartilage  proteoglycan  
(aggrecan) and hyaluronan  in  cartilage  
extracellular  matrix,  thereby  stabilizing  their 
aggregation and producing supramolecular 
assemblies. 
cartilage 
40 
Matrix Gla 
protein 
• Act as an inhibitor of calcification in arteries. cartilage  
and most  
visceral organs 
41 
MMP (matrix 
metalloprotei
nases) 
• cleaves collagens type I, II, III, VII, VIII and 
X,  in addition to gelatine (non-triple helical 
collagen) ,proteoglycan, etc 
• Play a major role on cell behaviors such as cell 
proliferation, migration (adhesion/dispersion), 
differentiation, angiogenesis, apoptosis, and 
host defense. 
Skin, basement 
membrane  
42 
Entactin/nido
gen 
(sulphated 
glycoprotein) 
• It associates specifically with both laminin (in 
a  1 : 1  molar ratio) and type IV collagen and 
is thought to play an important role in linking 
these two molecules together in the basement 
membrane 
Basement 
membranes 
43 
Perlecan 
(large 
proteoglycan)  
• It endows basement membranes with fixed 
negative electrostatic charge and is 
responsible, in part, for the charge-selective 
ultra-filtration properties of this extracellular 
Basement 
membranes 
44 
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matrix. 
• It interacts with other basement membrane 
components such as laminin and collagen type 
IV, and serves as an attachment substrate for 
cells. 
Aggrecan( a  
large  
Chondroitin 
sulphate 
proteoglycan) 
• to swell and hydrate the  frame work of 
collagen fibrils in cartilage 
Cartilage  
45 
Bamacan(cho
ndroitin 
sulphate 
proteoglycan) 
• stabilize the chromosomal scaffold at mitosis basement 
membranes 
46 
Biglycan 
(small CS/DS 
proteoglycans
) 
• Biglycan interacts with collagen, 
• Mineralisation of bone. 
• Biglycan core protein binds to the growth 
factors BMP-4 and influences its bioactivity 
bone ,cartilage  
and  aorta 
47 
Cartilage 
matrix 
protein 
• may act as a marker for post-mitotic 
chondrocytes 
tracheal,  nasal  
septal,  
xiphisternal,  
auricular and 
epiphyseal 
cartilage, but not 
in articular 
cartilage or 
extracts of the  
intervertebral  
disc. 
48 
Chondroadhe
rin (leucme-
rich  
glycoprotein) 
• mediating cell  attachment  of  chondrocytes  
to  plastic,  although  it  does  not  promote  
cell spreading,   
Cartilage. 
49 
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Dentin matrix 
phosphoprote
in 
• Play a role in mineralization. Teeth, calvaria, 
preameloblasts. 
50, 51 
Fibronectin 
(glycoprotein
)  
 
• Fibronectin attaches cells to all matrices 
except type IV that involves laminin as the 
adhesive molecule 
• Cellular migration during development and 
wound healing, regulation of cell growth and 
differentiation, and haemostasis/thrombosis. 
Basement 
membranes, 
cartilage, 
adipose tissue   
52 
Fibulin 
(glycoprotein
) 
• to interact with numerous extracellular matrix 
constituents including fibronectin, 
proteoglycans, laminins and tropoelastin 
Basement 
membranes  
53 
 
2.2. Significance of ECM as scaffolding material:  
ECM is a novel biomaterial for tissue engineering application, because it plays a major 
role in cellular growth, proliferation, cell attachment and movement of cells, etc. ECM 
scaffolds are highly compatible with tissue. The scaffolds even after sterilisation retain some 
growth factors, functional proteins and cytokines. Because of the component diversity in the 
ECM it helps in cell anchoring, cell metabolism also 
[54, 55]
. following points describe the 
importance of ECM as scaffolding material in detail.  
• ECM influences the cell phenotype and control the cell proliferation and cell 
differentiation also. Researchers found that ECM from Urinary Bladder Matrix (UBM) 
strongly affects smooth muscle cells phenotype, differentiation, etc 
[56]
. 
• When ECM implanted in to body it start to remodel then degrading or resorbing like 
other scaffolds. During the remodelling the cells from neighbouring tissues will 
repopulate in to scaffold and cells like blood-borne and marrow-borne derived cells 
18 
 
migrate to the site of implantation and then they will start to differentiate in to a 
particular phenotype
 [57]
. 
• ECM scaffolds possess can posses variety of mechanical characters because the 
mechanical properties depends of many variables like source of ECM (xenogenic 
[58]
 
human, body location, etc), different processing methods (Decellularization methods 
[59]
 
cross linking and sterilization methods 
[60, 61]
 both the tissue and scaffold should posses 
similar compliance and should have same mechanical property of target tissue 
otherwise it may leads to failure in vivo.  
• The ECM Scaffolds shown resistance to infection after contamination with bacteria or 
gastrointestinal contents 
[62-64]
, after the transplantation of scaffold in to human body it 
will start degradation. During the biodegradation process small peptides (5 kDa to 
16kDa) released from the fibers like collagen , these molecules mimic some peptides 
that inhibit the growth of gram positive and gram negative bacteria in in vitro 
[65]
. 
The preclinical studies show that ECM scaffolds shown resistance towards deliberate 
bacterial contamination 
[66, 67]
. The clinical studies of ECM performed shown resistance 
towards spontaneous contamination 
[68-70]
. 
• ECM Scaffolds also shows chemoattractant properties [62]. The components derived 
during the biodegradation process helps in the recruitment of cells to the remodelling 
site, and help in the tissue specific differentiation by mechanical and biochemical 
signals 
[70, 71]
. In a in vivo study ECM shows an attractive property towards circulating 
bone marrow-derived cells and they will remain in the remodelled tissue 
[72, 74]
.  
• ECM plays an important role in stem cell differentiation [75]. Many studies shows that 
decellularized ECM help in the stem cells differentiation and maintain the phenotype of 
the differentiated cell line in a tissue specific manner 
[54, 76, 77]
.  
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• The peptides released during the biodegradation on ECM components like collagen, 
elastin, laminin and fibronectin participate in mellaprotease matrix  metalloprotease 
(MMP) expression, Cellular activity modulation and growth factor signalling, tumour 
vascularisation and angiogenesis 
[74, 78, 79]
. 
Because of theses significance ECM scaffolds becoming popular in market some of them are 
tabulated in (Table 2)  
Table 6: ECM products available in market 
 ECM Product 
Name  
Company  Source of ECM Applications  
Ref 
1 Oasiss® Wound 
matrix  
& 
Oasiss® Ultra Tri-
Layer Matrix 
Healthpoint Porcine small 
intestinal 
submucosa 
(SIS) 
• Partial and full-thickness 
wounds 
• Pressure ulcers 
• Venous ulcers 
• Chronic vascular ulcers 
• Diabetic ulcers 
• Trauma wounds (abrasions, 
lacerations, second-degree 
burns, skin tears) 
• Draining wounds 
• Surgical wounds (donor 
sites/grafts, post-Mohs' 
surgery, post-laser surgery, 
podiatric, wound dehiscence) 
80 
2 TissueMend® TEI 
Bioscience  
fetal and 
neonatal bovine 
acellular dermal 
matrix 
• Tendon repair surgery, 
including reinforcement of the 
rotator cuff, patella, achilles, 
biceps, quadriceps, or other 
tendons. 
81 
3 Xenform
TM
 TEI 
Bioscience 
fetal and 
neonatal bovine 
acellular dermal 
matrix 
• to restore vaginal form and 
function after a pelvic floor 
procedure 
81 
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4 Durepair ® TEI 
Bioscience 
fetal and 
neonatal bovine 
acellular dermal 
matrix 
• repair of the dura mater 
during neurosurgical 
procedures 
81 
5 PriMatrix AG
 TM
 TEI 
Bioscience 
fetal and 
neonatal bovine 
acellular dermal 
matrix 
• Skin ulcers 
• Trauma wounds 
• Second degree burns 
• Full thickness wounds 
• Partial thickness wounds 
• Surgical wounds 
• Post-Mohs surgery 
• Tunneled wounds 
81 
6 SurgiMend PRS 
TM
 
TEI 
Bioscience 
fetal and 
neonatal bovine 
acellular dermal 
matrix 
• Designed specifically for 
plastic and reconstructive 
surgery and made of pure 
collagen that provides sound 
support for rapid healing – 
without inflammation. 
81 
7 MemoDerm MMI Foot 
and Ankle 
Human dermis • Rotator Cuff 
• Anterior Shoulder Capsule 
• Flex/Extensor Tendon 
• Ulnar Collateral Ligament 
• Achilles Tendon 
• Lateral Ankle Complex  
• Chronic Diabetic foot Ulcer 
82 
8 DermaMatrix DePuy 
Synthes 
Human dermis • Facial—soft tissue defects 
•  nasal reconstruction  
• septal perforation 
•  parotidectomy 
• Intraoral—cleft palate repair, 
•  oral resurfacing 
• Vestibuloplasty 
• Radial forearm free flap 
repair 
• Breast reconstruction 
postmastectomy 
83 
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• Abdominal wall repair. 
9 AlloDerm LifeCell Human dermis • Intact repair in challenging hernia  
• breast reconstruction postmastectomy 
84 
10 GraftJacket ® Wright 
Medical 
Technology 
Human dermis • Replacement of damaged or 
inadequate integumental 
tissue.  
85 
11 MATRI DERM ® Ideal 
TM
 
Medical 
Solutions  
Bovine dermis • burns or other kind of injuries 
to the skin 
86 
12 MatriStem™ 
Wound Care 
Matrix 
Medline Porcine urinary 
bladder 
Matrix 
• Chronic and acute wounds 
(partial and full-thickness, 
draining, trauma, surgical)  
• Ulcers (diabetic, venous, 
pressure, and chronic 
vascular). 
87 
13 EZ-DERM ® WOUNDSO
URCE 
Porcine dermis • Partial-thickness skin loss, 
donor sites, skin ulcerations 
and abrasions 
• Temporary covering for full-
thickness skin loss, Toxic 
Epidermal Necrolysis (TEN) 
and meshed autograft 
protection. 
88 
14 Biodesign® 
(Surgisis®) 
Cook 
Medicals  
Porcine small 
intestine 
submucosa 
(SIS) 
• Hernia Repair 
• Fistula Repair 
• Plastic & 
Reconstructive/ENT 
• Staple Line Reinforcement 
• Peyronie‘s Repair 
• Continence Restoration 
• Dural Repair 
• Pelvic Floor Repair 
89 
15 Permacol™ COVIDIEN Porcine dermis • complex hernia repairs 
• abdominal wall 
reconstruction 
90 
16 CollaMend* BARD Porcine dermis • hernia  91 
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Implant DAVOL 
LNC    
• Abdominal wall repair. 
17 XenMatrix™ 
Surgical 
Graft 
BARD 
DAVOL 
LNC    
Porcine dermis • hernia  
• Abdominal wall repair. 
92 
18 BIOPAD ® Argentum 
medical 
LLC 
Equine flexor 
tendon 
• ulcer and skin lesion to help 
wound closure 
93 
19 Strattice™ 
Reconstructive 
Tissue Matrix 
Life Cell Porcine dermis • Abdominal wall 
reconstruction 
• Breast reconstruction 
postmastectomy 
• Breast plastic surgery 
94 
20 Endoform™ 
Dermal 
Template 
Mesynthes  Propria-
submucosa 
layers of ovine 
forestomach 
• partial and full-thickness 
wounds 
• pressure ulcers 
• venous ulcers 
• diabetic ulcers 
• chronic vascular ulcers 
• tunnelled/undermined 
wounds 
• surgical wounds (donor 
sites/grafts, post-Moh's, post-
laser, podiatric, wound 
dehiscence) 
• trauma wounds (abrasions, 
lacerations, second-degree 
burns, and skin tears) 
•  draining wounds 
95 
21 Veritas® Collagen 
Matrix 
Synovis  Bovine 
pericardium 
• hernia repairs 
• plastic and reconstructive 
surgeries,  
• Pelvic floor procedures. 
96 
22 SureDerm™ 
Acellular 
Dermal Graft 
HANS 
Biomed  
Human dermis • Soft tissue coverage 
• Hypertrophic scar revision 
• Facial soft tissue repair 
97 
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• Skin defect, Burn wound 
allograft 
• Protective covering for 
nerves, tendons 
23 AlloMax™ 
Surgical Graft 
BARD 
DAVOL 
LNC    
Human dermis • hernia  
• Abdominal wall repair. 
98 
24 NeoForm™ Mentor 
Corporation 
Human dermis • Breast Reconstruction 99 
25 FlexHD® 
Acellular 
Hydrated Dermis 
Ethicon  Human dermis • Breast Reconstruction 10
0 
26 CuffPatch
TM
 BioArthro human amniotic 
tissue 
• Rotator cuff repair. 10
1 
27 Tendon Wrap
TM
 BioArthro human amniotic 
tissue 
• Protection of tendons after 
repair. 
10
2 
28 Durasis® Cook 
Medicals 
Porcine small 
intestinal 
submucosa 
(SIS) 
• for repairing dura mater 10
3 
29 Stratasis® Cook 
Medicals 
Porcine small 
intestinal 
submucosa 
(SIS) 
• Treat stress urinary 
incontinence resulting from 
urethral hypermobility (Type 
II) and/or intrinsic sphincter 
deficiency. 
10
4 
30 OrthADAPT 
TM
 Pegasus 
Biologicals 
Horse 
pericardium 
• Posterior Tibial Tendon 
Repair  
10
5 
31 BioSet® PENTA 
BIOMEDIC
AL 
Human bone  • Bone regeneration  10
6 
32 Sterling® PENTA 
BIOMEDIC
AL 
bovine bone • Bone regeneration 10
7 
33 Restore
TM
 DePuy Porcine small • To reinforce soft tissue where 10
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intestinal 
submucosa 
(SIS) 
weakness exists, specifically 
for areas of soft tissue 
repaired by sutures or suture 
anchors, including the rotator 
cuff, patella, achilles, biceps, 
quadriceps, and other tendons 
8 
34 Dura-Guard® Synovis 
Surgical 
Bovine 
pericardium 
• Tumor resection 
• Trauma 
• Congenital disorders 
• Cerebrovascular disorders 
10
9 
35 Vascu-Guard® Synovis 
Surgical 
Bovine 
pericardium 
• Carotid endarterectomy 
• Profundaplasty 
• Arteriovenous access 
revisions 
• Femoral, iliac, renal and tibial 
patching 
11
0 
36 Peri-Guard® Synovis 
Surgical 
Bovine 
pericardium 
• Pericardial closure 
• Intracardiac repair 
• Great vessel repair 
• Septal and annulus repair 
• Soft tissue repair (abdominal 
wall defect, thoracic wall 
defect, hernia.)  
11
1 
37 Zimmer Collagen 
Patch® 
Tissue 
Science 
Laboratories 
Porcine dermis • Reinforcement of large 
tendon tears at the repair site 
11
2 
 
2.3. Preparation of ECM- Decellularization:  
Decellularization is used to remove the immunogenic cellular components from the 
tissue without hampering molecular structure and orientation of extracellular matrix 
components. 
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Differ physical, chemical and enzymatic methods are available for the 
Decellularization.  Use of combination of different Decellularization methods showed better 
result than using individual methods. 
An Ideal Decellularization should not affect the structure and properties of 
extracellular components like collagen, elastin, glycosaminoglycan etc. But in reality all the 
Decellularization protocols shows some drawbacks. 
 Freeze-thaw cycle is a common physical Decellularization method; the ice crystals 
formed during the process disrupt the cell membrane but as well as they can fracture ECM 
also. Alkali and acid treatment help to solubilise cytoplasmic components and degrade 
nucleic acids but the digestion cause the loss of GAGs. 
 Detergents are effective decellularising agents because they have a great role in 
plasma membrane disruption. Ionic, non ionic and Zwitter ionic detergents can be used for 
the Decellularization but their mode of action will be different. Non ionic detergents like 
Triton X100 Disrupts lipid–lipid and lipid–protein interactions but GAGs content after the 
treatment will decrease. Ionic detergents like Sodium dodecyl sulfate (SDS) Solubilise 
cytoplasmic and nuclear cellular membranes but they denature collagen and other proteins 
and also decrease the GAGs concentration in the ECM. Zwitterionic detergents like CHAPS 
show the properties of both ionic and non ionic detergents. Cell lysis can be archived by 
osmotic shock by a hypertonic solution like highly concentrated sodium chloride solution but 
the removal of cellular component needs further processing.  
 Enzymatic treatments also can be used for Decellularization. Trypsin is an enzyme 
which commonly used for Decellularization process but prolonged exposures of the trypsin 
can loss of different ECM components. Immunogenic components can be removed with the 
help of endonucleases and exonucleases but the sample should be washed thoroughly after 
treatment because the removal of enzymes is very difficult it can leads to immune responses.  
26 
 
Table 7: Decellularisation method for different tissues 
Sl 
No  
Tissue  Decellularization methods  Ref 
1  myocardial 
tissue  
1% (wt/vol) sodium dodecyl sulfate (SDS) for 4-5 days 
1% (vol/vol) Triton X-10 0 for 30 min  
stir overnight in deionized water to ensure removal of detergents  
113  
2  urinary 
bladders  
Isolation of UBM (Soak in 1N Saline or water (Urothelial layer removal) 
and Mechanically delamination of The tunica serosa, tunica muscularis 
externa, tunica submucosa, and most of the muscularis mucosa) 
0.1% (v/v) peracetic acid, 4% (v/v) ethanol, and 96% (v/v) deionized 
water for 2 hours. 
phosphate-buffered saline (pH- 7.4) wash twice (15min each) 
deionized water. Wash twice (15 min each)  
114, 
115 
3  Adipose 
tissue  
Freeze-thaw 3 times 
Incubate for 16 hours (overnight) in Enzymatic Digestion Solution 1 
 Polar solvent extraction in 99% isopropanol 
Rinse 3 times (30 minutes each) in Sorenson‘s Phosphate Buffer  
Incubate for 6 hours in Enzymatic Digestion Solution 1  
Rinse 3 times (30 minutes each) in SPB 
Incubate for 16 hours (overnight) in Enzymatic Digestion Solution 2  
Rinse 3 times (30 minutes each) in SPB 
 Polar solvent extraction in 99% isopropanol (8 hours) 
Rinse 3 times (30 minutes each) in SPB  
54,  
116 
4  Liver   portal perfusion with SDS  117  
5  Adipose 
Tissue  
Homogenization  of tissue: water mixture (2:1) for 3 min with pulsation 
Centrifugation for oil separation (3000 rpm for 5 min) 
Distilled water wash for several times 
Viscous suspension cast in a shallow mold 
Freeze drying  
0.5% SDS wash of scaffold for 1hr at room temperature  
Wash properly with distilled water for 24hrs at 4⁰C 
55  
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6  small 
intestinal 
submucosa 
(SIS)  
Mechanical Delamination (to remove the luminal portions of the tunica 
mucosa, including the majority of the lamina propria, and the tunica 
muscularis externa and serosa)  0.1% (v/v) peracetic acid (σ), 4% (v/v) 
ethanol, and 96% (v/v) deionized water for 2 h  washed twice for 15 min 
with PBS (pH = 7.4) and twice for 15 min with deionized water  
118-
120, 
7  Liver  Freezing of liver lobes(-80⁰C) 
Cut in to slices of 5mm 
Treat with enzymatic and detergent solutions  
DI water wash for 30 min (3 times) 
Treat with 0.02% trypsin/0.05% EDTA at 37⁰C for 1 h 
Rinse in DI water 
Treat with 3% Triton X-100 for 1hr 
Place the slices in 4% sodium deoxycholic acid for 1 h  
Rinse with DI water  
118 
8 Adipose 
tissue  
Thawing of tissue 
Mechanical massaging 
0.02% trypsin/0.05% ethylenediaminetetraacetic acid 
Rinse in distilled deionized water 
Mechanical massaging 
3% triton X-100 
Rinse in distilled deionized water 
4% sodium deoxycholate 
Rinse in distilled deionized water 
4% ethanol/0.1% peracetic acid 
Rinse in PBS and distilled deionized water 
Lyophilization  
100% n-propanol 
Rinse in distilled deionized water 
Lyophilization  
121  
9 Adipose 
tissue  
1% sodium dodecyl sulfate (SDS) in deionized (DI) water or 2.5 mM 
sodium deoxycholate in 1X PBS (48h) 
2.5 mM sodium deoxycholate in 1XPBS supplemented with 500 U of 
porcine lipase and 500 U of porcine colipase (24-48h) 
Lyophilisation and milling  
122  
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10 Adipose 
tissue  
tissue/water mixture was homogenized at 12,000 rpm for 5 min  
Centrifuged at 3000 rpm for 5 min and the upper layer containing oil 
components were discarded. 
Repeated above steps several times 
Freeze drying and milling  
123, 
124 
11  Adipose 
tissue  
homogenized at 12,000 rpm for 5 min at room temperature  
Centrifugation and oil removal 
1M hyperosmolar solution of NaCl (diluted 1:1) for 2 h at 37⁰C 
Centrifugation and oil removal 
Rinsing with distilled water for 24 h at 4⁰C  
0.5% sodium dodecyl sulfate (SDS) for 1 h at room temperature 
Centrifugation and water wash 
0.2% DNAase (2000U) and 200 µg/mL RNAase for 1 h at 37⁰C 
Centrifugation and water wash.  
123  
12  Skeletal 
muscle  
Chloroform/methanol (2:1 v/v) extraction of lipid 
Graded series of alcohol (100,90,70,50,0)  30min each 
0.2% Trypsin/0.2% EDTA at 37 ⁰C (2h) 
Deionized water, 2XPBS (30min each) 
2% sodium deoxycholate (5h) 
Deionized water, 2X PBS (30min each) 
2% sodium deoxycholate for 14-16h 
1% Triton X-100 for 1h 
Deionized water (30min) 
0.1% (w/v) peracetic acid/4% ethanol (v/v) (2h) 
1 X PBS, 30 min each twice  
Deionized water, 30 min each twice. 
125 
13 Dermis  Mechanical delamination (The subcutaneous fat, 
connective tissue, and epidermis were removal) 
1 cycle freeze thaw (-80⁰C - 37⁰C) 
0.25% trypsin for 6h 
 three 15 min washes of deionized water 
70% ethanol for 10 h 
3% H2 O2 for 15 min 
 two 15 min washes of deionized water 
1% Triton X-10 0 in 0.26% EDTA/0.69% Tris for 6 h 
with a fresh change for an additional 16 h 
126 
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three 15 min washes of deionized water 
0.1% peracetic acid/4% ethanol for 2 h 
two 15 min washes of PBS 
two 15 min washes of deionized water.  
14 central 
nervous 
system 
(optic 
nerve, 
spinal 
cord, and 
brain)  
frozen ( >16 h at 80 ⁰C), thawed  
separated  all non CNS Tissue 
cut into lengths ( <3 cm) 
Agitations in following reagents : Agitation 
speed was 20 0 rpm for optic nerve and spinal cord tissues or 120 rpm for 
brain tissue with the exception of the initial step at 60 rpm.  
water (type I reagent water per ASTM D1193; 16 h at 4 ⁰C; 60 rpm) 
0.02% trypsin/0.05% EDTA (60 min at 37 ⁰C) 
 3.0% Triton X-100 (60 min) 
1.0 M sucrose (15 min) 
 water (15 min),  
4.0% deoxycholate (60 min) 
0.1% peracetic acid  in 4.0% ethanol (120 min) 
PBS (15 min)  
water (15 min) (2 times) 
PBS (15 min)  
Lyophilization.  
127  
15 Cartilage  The suspension of cartilage fragments was spun in centrifuge for 5 min at 
2000 rpm  
Removed the deposit 
New suspension recentrifuged  for 5 min at 7000 rpm 
incubated in 1% TritonX-100 in hypotonic Tris HCl with gentle agitation 
for 12 h at 4 ⁰C 
 12 h in 50 U/mL deoxyribonuclease I and 1 U/mL ribonuclease A in 10 
mM Tris HCl, pH 7.5 
washed in PBS intensively  
128  
16 Tracheal 
Tissue  
 1 hour in 0.25% Trypsin/0.05% ethylenediaminetetraacetic acid at 37°C 
48 hours in deionized water at 4°C 
48 hours in 3% Triton X-100 at 4°C 
 rinsed heavily 
Lyophilisation  
129  
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17  pericardial 
tissue  
40 ml of sterilized and ﬁltered PIPES buffered saline solution (PSS, 30 
mM, pH 7.4, 0.9% NaCl) containing 0.4 ml of tridecyl alcohol ethoxylate 
(1% v/v) and treated at 4 ⁰C for 48 h under orbital stirring (20 rpm). 
The solution containing the surfactant was changed after 24 h and after 
this period of time, the samples were washed with PSS  
130  
 
2.4. ECM Scaffold Crosslinking and sterilization 
• Crosslinking of ECM Scaffolds: 
Cross linking methods used to improve different parameters of the scaffold like mechanical 
strength,biodegradability, thermal stability etc. ECM Crossliniking offers following 
advantages  
• Increase ECM strength and achieve consistent mechanical properties  
• To improve compressive stiffness 
• To decrease biodegradability  
• To inhibit recognition of surface epitopes by host that is to reduce antigenicity  
• To inhibit cellular infiltration to the scaffold 
Crosslinking can be achieved by different methods like Chemical crosslinking and 
Biophysical methods. Chemicals like Carbodiimides (eg: 1-Ethyl-3-3-dimethyl aminopropyl 
carbo-diimide EDAC), N-hydroxy sucinimide, Glutaraldehyde GTA, Hexamethylene 
diisocyanate can be used for crosslinking. EDAC form zero length cross links, which are 
chemically identical to formed by dehydrothermal method (a biophysical method). GTA links 
form long polymer chains, so EDAC can crosslink fiber with a distance less than 1nm only, 
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but GTA can crosslink fibers with distance. GTA crosslinked have ability to support 6.4times 
as many cells as the standard dehydrothermal (biophisical method).  
Chemical crosslinking can cause damages to ECM, the drawbacks are as follows 
• Chemical cross linking changes ultra structure of ECM scaffold however it 
cause minimal changes to molecular composition 
• It may alter presentation and confirmation of ligands on the ECM surface thus 
altering ligand-receptor interactions 
• GTA and  Hexamethylene diisocyanate reduce the ability of cells to interact 
with treated material and to cause cutaneous sensitization and to lead to calcification  
• May inhibit cell migration and vascular regeneration.  
• Residual crosslinker may produce inflammatory response  
Because of above mentioned drawbacks researchers using biophysical methods like 
dehydrothermal treatment, UV irradiation etc.  In dehydrothermal treatment scaffold 
is treated at high temperature in vacuum for 12-24 hrs. During the dehydrothermal 
treatment water removed will create some links between strands of collagen, elastic 
fibers etc.  
• Sterilization of of ECM Scaffolds: 
Sterilization of scaffold is very important to reduce risk of disease and required for FDA 
clearance. Peracetic acid, ethylene oxide treatment, gamma irradiation are the commonly 
used sterilization methods for ECM.  
Peracetic acid PAA: (0.1-0.15%): During the treatment the PAA enter in to microbial 
cells and oxidize microbial enzymes and it also kills human cells also so it can be used for 
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Decellularization. But PAA oxidize the matrix and reduce structural integrity of collagen 
fiber oxidative destruction of GAGs fracture them, impairs their ability to interact with 
growth factors and subsequently increases the susceptibility of growth factors to denature. 
Ethylene oxide gas: is widely used sterilization method for ECM products because other 
available methods have deleterious effects. The gas causes the alkylation of matrix and 
helps to makes the scaffold free from microorganism including bacteria. But alkylate 
matrix proteins, rendering them inactive and undetectable. PAA and Ethylene oxide 
treatment ensure viral safety and sterility. Ethylene dichloride (EDC) also a sterilizing 
agent but during treatment it preserve collagen structure in tissue.  
Chemical used for sterilization can trapped inside scaffold and may cause inflammatory 
response in this scenario gamma irradiation have great importance. Different range of 
Gamma irradiation can be used for sterilization. At low dosage of gamma irradiation 
(<15KGy), the strength and modulus of scaffold increased but mechanical property 
decreased above 15KGy in a dose-dependent manner. The change is due to the increase in 
collagen cross-linking due to the low dose of irradiation that levels off after 
approximately 5KGy, along with collagen chain scission that continues to increase with 
irradiation dose.  
2.5. Nano Hydroxy apatite  
Nanosized hydroxyapatite (HA) is the main component of mineral bone. The bone 
remodelling comprises of a coupled resorptive-formative process where all the living 
bones undergoes this process constantly. The bone cells osteoblast and osteoclast brings 
about simultaneous bone removal and replacement process through their respective 
activities.  
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HA possesses similarity with the hard tissues of the body with its exceptional 
biocompatibility and bioactivity with bone cells and tissues. These calcium phosphate 
biomaterials have been widely used in different forms such as powders, granules, dense 
and porous blocks and various composites in the clinical field. The main mineral part of 
calcified tissues is formed by these calcium phosphate materials only. But this calcium 
phosphate present in the form of nano meter-sized needle-like crystals of  5-20 nm width 
and 60 nm length approximately in the bone, with a poorly crystallized non-
stoichiometric apatite phase containing various ions like (CO3)
2–
, Na
+
 and F
–
 in a collagen 
fiber matrix.  
Compared to other conventional ceramic formulation. HA properties such as surface 
grain, wettability, pore size, etc, can be varied to control protein interactions. So that one 
can modulate the adhesion of osteoblast and its long term functionality. Webster et al 
[32-
134]
 found that by controlling this properties osteoblast functions such as proliferation, 
alkaline phosphatase synthesis and calcium containing mineral deposition can be 
enhanced. These properties not only promote increased selective vitronectin adsorption 
and also affect conformations which can enhance osteoblast functions. 
2.6. Bio-orthopedic properties of nanoHA 
The removal of infected bone tissue or bone tumours leads to the need of bone 
substitutes for a individual. The first desirable form of bone substitutes is autologous 
bone. However, autografts have their own disadvantages like availability and morbidity at 
the donor site. Second desirable form is an allograft, but there is also possibility of host 
immune response and disease (i.e. human immunodeﬁciency virus (HIV) or hepatitis B) 
transmissions to the recipient 
[135]
. Hence the advantages of Bone graft substitutes over 
both autografts and allografts bring about the attraction in recent years 
[136]
. Bone 
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substitutes is simply a biomaterial having properties such as biomimetic poor crytallline, 
carbonate substituted apaptite with good mechanical strength to mimic natiural bone 
[137]
. 
HAp artiﬁcial bones showed satisfying repair function as in the of clinical field over the 
past years 
[138–140]
. Inspite of their success they possess some weak-nesses, such as weak 
intensity and slow degradation. Current research has been in progress to improve the 
properties of HA to meet both biological properties and the mechanical properties of the 
natural bone 
[141]
.  
  Recently HAp coating on scratched areas of a human tooth and HAp disks by 
the immersion method in a HAp colloidal solution were reported 
[142]
. The surface 
morphologies of the damaged surfaces were remarkably recovered after 3 months of 
immersion of HA. The cell study with mouse calvaria-derived pre-osteoblast cells 
(MC3T3-E1) showed that HA layers could be suitable for maxillofacial and orthopedic 
applications. Another interesting result showe by the same research group that nanoscale 
HA powders (mean particle size-200 nm) were used to regenerate the enamel layers of 
damaged teeth 
[143]
. A nanoscale HAp powder suspension in deionized water was 
immersed in an artiﬁcially scratched tooth for a period of 1–3 months. After 3 months, the 
scratched surface was ﬁnally examined where there is increase in the roughness , newly 
generated HA layer which was very similar to that of innate layer. Ca
2+
 and (PO3) 
4-
 ions 
from the HA were precipitated on the tooth to produce cement pastes on the enamel 
surface resulting in the formation of new HA layer. This nanoscale HAp powder solution 
might be used to heal decayed teeth as well as to develop tooth-whitening materials. A 
synthetic bone in sinus bone grafting called SB-1™ consists of synthetic HAp with 500–
1400 l m particle size and chemical composition similar to that of inorganic part of 
human bones. It was found through an in-vivo study with rabbit that SB-1™ was 
exceptionally good in terms of bonding with host bones and also inducing the formation 
35 
 
of new bone as well as integration with new bone in comparison with other allografts and 
low HA bone grafts. 
 The osteoconductive properties of nano-HA material and its potential application 
were evaluated by Zhu et al. 
[135]
 on the basis of the cross-sectional area ﬁlled with 
mineralized bone by HA scaffolds. And the study showed that highly porous and 
interconnected HA scaffolds synthesized were potentially suitable for the orthopedic 
application 
Table 8: Current status of Research on ECM based tissue engineering 
1 ECM source  Decellulariz
ation 
method 
Solvent 
paramet
ers 
ECM Treatment Result Ref 
1 1.porcine 
small 
intestinal 
submucosa(S
IS) 
2.porcine 
urinary 
bladder 
submucosa(
UBS) 
3.porcine 
urinary 
bladder 
matrix(UBM
) 
4.a 
composite of 
5.UBS+UB
M 
canine 
stomach 
submucosa 
 
Mechanical 
delaminatio
n 
-- 0.1%Peracetic acid 
treatment with 4% 
ethanol  ( 
disinfection)  
& 
Vacuum drying  
Multilaminate 
extracellular matrix 
devices by 
mechanical pressing. 
Different 4 layer and 2 layer laminated 
devices of UBS, UBM and SIS shown 
different mechanical property. So according 
to the strength of target soft tissue we can 
produce scaffolds by lamination method 
using ECM. 
142 
2 Pig UBM 
Pig SIS 
Pig  
Liver 
ECM(LECM
) 
 
UBM & 
SIS: 
mechanical 
delaminatio
n 
LECM: 
Trypsin, 
EDTA, 
Triton X-
-- Peracetic acid 
treatment  
& Crosslinking : 
either carbodiimide 
ethylene oxide gas 
sterilization  
 
The structural and morphological characters 
of scaffold depend on many factors like 
source of tissue or organ. Chemical cross 
linking affect the surface characteristics of 
ECM scaffolds.  
143 
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100, sodium 
deoxycholic 
acid, 
peracetic 
acid, 
ethanol 
treatment  
3 Acellular 
PCL/ECM 
composite 
PCL-
Cartilaginous 
ECM 
Fibers 
(Electrospinn
ing) 
 
 
Freeze 
thawing  
 
PCL (14 
wt %) in 
a of 
chlorofo
rm to 
methano
l (5:1 
volume 
ratio). 
ﬂow 
rate of 
18 mL/h 
Voltage 
25.5 kV 
After 
Decellularization, -
ﬁtted into 
Cassettes  
Sterilization: 
ethylene oxide gas 
for 14 h  
ECM can stimulate stem cell differentiation. 
ECM-PCL composite scaffold support 
chondrogenic differentiation.  
144 
4 Human bone 
marrow 
mesenchyma
l stem cells 
(MSCs), 
normal 
human 
dermal 
ﬁbroblasts 
(NHDF, and 
)  normal 
human 
articular 
chondrocytes 
(NHAC) 
cultured on 
PLGA mesh 
and 
decellularize
d the 
construct.  
Freeze 
thawing (6 
times -80⁰C 
to room 
temperature
)  
and 
Ammonia  
treatment  
-- PLGA mesh 
solubilisation by 
trisodium phosphate  
freeze-dried 
The ECM scaffolds shown excellent 
biocompatibility when implanted to animal 
model. By culturing method they developed 
allogenic scaffolds.. 
145 
5 Canine 
skeletal 
muscle ECM 
(M-ECM) 
porcine (SIS) 
M-ECM: 
Chloroform/
methanol, 
Trypsin, 
EDTA, 
sodium 
deoxycholat
e, Triton X-
100, 
peracetic 
-- Lyophilized and 
sterilized with 
ethylene oxide gas 
The M-ECM shows effects on myogenic 
cells in vitro and help in positive 
remodelling in rodent muscle defect model. 
tissue speciﬁc M-ECM  was not showing 
any significant advantage over homologous 
SIS scaffolds 
146 
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acid 
 
6 porcine optic 
nerve, spin al 
cord, and 
brain ECM 
 
Trypsin, 
EDTA, 
Triton X-
100, 
sucrose,  
Deoxychola
te,  peracetic 
acid 
treatments  
-- lyophilized The ECM scaffolds developed influences 
proliferation; differentiation and migration 
of PC12 cell lin in vitro. Central nerve 
system CNS and non-CNS acellular matrix 
is the best scaffold for  neural tissue 
remodelling and CNS repair  
 
147 
7 mineralized  
(ECM) and 
electrospun 
poly(e -
caprolactone) 
(PCL) 
microﬁber 
scaffolds 
freeze and 
thawing  
( 3 cycles- 
LN2 -37⁰C) 
PCL (14 
wt %) in 
a of 
chlorofo
rm to 
methano
l (5:1 
volume 
ratio). 
ﬂow 
rate of 
18 mL/h 
Voltage 
25.5 kV 
Sterilization: 
ethylene oxide gas 
for 14 h 
The scaffold developed stimulates 
osteogenic differentiation of MSCs in vitro. 
148 
8 Bovine 
articular 
cartilage 
ECM 
TritonX-
100, Tris 
HCl,  
DNAase I , 
RNAase A. 
 lyophilized scaffolds 
cross-linked by 
genipin solution 
sterilized by to 20 
kGy 
60
 Co irradiation 
The scaffold combined with BMSCs which 
are chondrogenic-induced developed in to 
functional tissue engineering cartilage in 4 
weeks of culturing.  
The BMSC start to secrete cartilage ECM 
that will enhance the biomechanical 
properties. 
149 
9 Human 
cartilage 
ECM 
Pulverizatio
n, 
differential 
centrifugati
on, TritonX,  
DNAase I , 
RNAase A  
 Cross-linking: DHT 
& carbodiimide. 
Sterilization by 
60
Co 
gamma radiation.  
The scaffold developed retains most of the 
bio molecules of ECM and possess good 
biocompatibility.  
The novel scaffold retains most of the 
cartilage. The scaffolds also help in the 
proliferation and differentiation of BMSCs 
in to chondrogenic cell lines.   
150 
10 porcine 
UBM 
Peracetic 
acid (PAA)  
 
 Mechanical pressing 
(plying) 
The plying method is a best method to 
develop multi layered UBM. And can 
developed scaffold with different 
mechanical property.   
151 
11 Porcine 
UBM 
Washing, 
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment-  
 
-- vacuum drying  
ethylene oxide 
sterilization 
idea of applying ECMs with an SA better 
than their intended imperfection did lead to 
more efficient TBC and C values in 
comparison to conventional urological TE.  
152 
12 Porcine 
(UBM), and  
UBM: 
delaminatio
-- carbodiimide 
crosslinking and 
The ECM scaffold developed applied for 
tracheal regeneration  successfully  
153 
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decellularize
d tracheal 
matrix 
(DTM) 
n, peracetic 
acid/ 
ethanol 
treatment-  
DTM: 
Trypsin, 
ethylenedia
minetetraac
etic acid, 
Triton X-
100  
ethylene 
oxide.sterilization.  
 
 
13 Porcine 
(UBM),  and 
(SIS) 
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment- 
-- vacuum pressing, 
lyophilised and 
sterilized with 
ethylene oxide  
Multi laminated ECM membranes  showed 
high elongation ability.  
properties. 
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14 Porcine 
(UBM) 
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment,  
--- -- The ECM scaffold developed applied for 
default mechanisms of esophageal repair  
successfully  
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15 porcine 
chondrocytes
-derived 
extracellular 
matrix 
PGA 
Scaffold as 
control 
Freeze 
thawing ( 3 
cycles of  -
20⁰C to 
room 
temperature
)  
at 12 h 
intervals. 
-- Freeze drying  
 
The scaffolds developed from ECM secreted 
by cultured cells provide a efficient 
environment for cartiliage tissue engineering 
in vitro.  
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16 human 
adipose 
tissue ECM 
Homogeniz
ation, NaCl, 
SDS 
DNAase & 
RNAase 
treatments 
 Freeze drying   The decellularized method was effective and 
preserved the scaffold architecture. Elastic 
property of ECM was maintained even after 
Decellularization. The scaffolds also 
promote host cell inﬁltration in vivo.  
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17 Porcine SIS  PAA  
Freeze 
drying  
 ethylene oxide 
sterilization 
Even after the treatment of Decellularization 
and sterilization retained Fibronectin, FGF-2 
and glycosaminoglycans in scaffold. 
But VEGF content reduced dramatically 
158 
39 
 
18 Porcine SIS 
ECM 
PAA 
disinfection 
of SIS 
Freeze 
drying 
 ethylene oxide 
sterilization 
The invitro bioactivity of processed SIS was 
examined on murine fibroblasts and PC12 
cells after subjecting them to the effect of 
peracetic acid disinfection, lyophilisation 
and ethylene oxide sterilization. The post-
sterilization SIS was specifically analyzed 
for its ability to enhance fibroblast 
attachment, stimulation of PC12 cell 
differentiation and upregulation of fibroblast 
VEGF secretion. The result showed 
increased attachment of fibroblast to 
sterilized SIS, retention of viability and 
increased secretion of VEGF to a two-fold 
level upon interaction with SIS matrix 
components. The PC12 cells were also 
observed to exhibit increase in neurite 
outgrowth as compared to controls due to 
stimulation by SIS matrix proteins. The 
scaffold can also be prepared for human use 
with significant bioactivity. 
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19 Porcine (SIS) delaminatio
n, peracetic 
acid/ 
ethanol 
treatment, 
  The use of xenogenic small intestine 
submucosa for the repair of the anterior 
crucitate ligament in goat model is a 
promising example of resorbable bio-
scaffold development. 
160 
20 Porcine 
(UBM)  
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment, 
 Sterilization: 2.0 M 
rad γ-irradiation 
Constructive remodeling of myocardial 
tissue for the replacement of excisional 
defects was facilitated by using UBM as 
replacement scaffold. 
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21 human 
adipose 
tissue ECM 
homogenize
d, 
centrifuged, 
freeze-dried, 
and ground 
to powders 
by milling 
 Sterilization by 
ethylene oxide (EO) 
gas 
In a particular in vivo study, the use of 
human ECM powder proved highly effective 
in promoting attachment and proliferation of 
cells in a three-dimensional (3D) cell 
culture. In this study, human ECM solutions 
containing adipose-derived stem cells 
(hASCs) were subcutaneously injected into 
nude mice. Eight weeks later, the growth of 
a large number of blood vessels and 
adipogenesis accumulating intracellular 
small lipid droplets were observed in the 
newly formed tissue. To summarize, the 
grafts showed a well patterned construct of 
adipose tissues without any signs of cystic 
spaces, tissue necrosis or fibrosis.  
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22  (UBM) and 
(SIS) 
delaminatio
n, peracetic 
acid/ 
ethanol 
-- Sterilization by 
ethylene oxide (EO) 
gas 
The success in Vascular tissue engineering 
has been shown to increase due to the use of 
ECM which promotes growth, proliferation, 
anchorage and migration of cells derived 
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treatment, from human vasculature. The architecture 
and other features of the scaffold also 
control the rate of adhesion and proliferation 
of cells. The phenotype of smooth muscles 
and their proliferation-differentiation 
mechanism control is observed to be 
influenced by UBM scaffold containing a 
rigid basal membrane. 
. 
23 Human 
Umbilical 
Vein 
Endothelial 
cells 
(HUVEC) 
ECM 
EDTA/PBS 
will help to 
detach the 
cells and 
ECM will 
remain in 
culture dish  
  The attachment and proliferation of 
heterologous HDMECs and dermal 
fibroblasts on mixed matrix and HUVECs 
ECM proved successful. The lingering after 
effects of dispase were found to be 
neutralized by the conditioned medium from 
HUVECs which could also be used for 
tissue culture of epidermal keratinocytes, 
HDMECs and dermal fibroblasts whose 
extracellular secretions are common.  
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24 UBM or 
expanded 
polytetrafluo
roethlyene  
(ePTFE) 
Mechanical 
delaminatio
n, hypotonic 
cell lysis, 
disinfection 
by peracetic 
acid 
(0.1%),. 
 Lyophilization, 
vacuum pressing,  
Biodegradation of UBM when implanted as 
an LV-free wall infarction patch was 
accompanied by the appearance of a 
fibrocellular tissue including contractile 
cells. Hence UBM was proved superior 
against synthetic material for cardiac 
patching and helps in myocardial 
replacement within 3 months 
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25 Porcine 
UBM 
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment, 
  The temporal and spatial architecture of 
innervations during the in vivo modeling of 
ECM scaffold used for the reconstruction of 
the esophagus and muscular body wall was 
demonstrated by the results of this study. A 
more detailed study in this prospect is 
required to be done. 
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26 Human 
Adipose 
tissue ECM 
Freeze-
thaw(3 
times 
enzymatic 
digestion  
 Polar 
solvent 
extraction. 
 
 A chemical drying 
method used for 
fabrication  
 
This tissue source was found to be an 
excellent source for the isolation of human 
ECM in large quantities which also includes 
basement membrane components. Various 
methods were developed for the extraction 
of large-volume intact ECM scaffolds with a 
preserved three-dimensional architecture. An 
inductive microenvironment for the 
adipogenic differentiation of human ASC 
was provided by decellularized adipose 
tissue. DAT scaffolds, as compared to 
control monolayer or cell aggregate cultures, 
showed a higher expression of adipogenic 
markers when analyzed using gene 
expression studies. 
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27 Human 
Adipose 
tissue ECM 
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment, 
 Air drying of ECM The use of DAT-based microcarriers as 
injectable adipose tissue specific scaffolds 
for a dynamic culture system of ASC 
adipogenesis was investigated. The results 
positively showed that the microcarriers 
prepared by dissolving DAT provided a 
natural substrate for induction of adipogenic 
differentiation of human ASCs in vitro, 
which confirms our earlier work with intact 
DAT scaffolds. Gene expression studies also 
indicated that DAT microcarriers induced 
the expression of PPAR g C/EBP a and LPL 
without having to provide adipogenic 
differentiation factors exogenously. 
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28 
 
 
 
 
 
Human 
Adipose 
tissue ECM 
 
 
 
 
 
 
Freeze-
thaw(3 
times 
enzymatic 
digestion  
 Polar 
solvent 
extraction. 
 
 
 
 
 
 
 
 
 
 
sterilized by 
ethylene oxide gas 
 
 
 
 
Decellularization and fabrication of human 
adipose tissue into thin ECM sheets was 
carried out through blending, pulverization, 
centrifugation, casting, freeze drying and 
SDS treatment. These sheets exhibited high 
porosity, pore connectivity and required 
mechanical properties of that of engineered 
scaffolds. Culturing of five different human 
cell types showed positive proliferation and 
integration into these decellularized ECM 
sheets. 
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29 human 
lipoaspirate 
SDS, 
sodium 
deoxycholat
e lipase and 
500 U of 
porcine 
colipase 
treatment  
 0.1 M 
HCl and 3200 IU 
porcine pepsin used 
for digestion  
The adipose matrix stripped off its cells 
shows a closer similarity in terms of 
biochemical composition and complexity to 
that of the native adipose ECM. The 
immunorejection concerns are minimized by 
the removal of both lipids and cellular 
contents, even if the allogenic source leads 
to formation of lipoaspirate. Small needle 
delivery is realized by its gelation property 
which takes place at body temperature itself, 
which further facilitates fine contouring of 
complex voids. Hence decellularized 
lipoaspirate produces an autologous soft 
tissue filler which is capable of gelling at 
body temperature and produces minimum 
immune response. 
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30 Human 
Adipose 
tissue ECM 
Homogeniz
ed 
Centrifugati
on  
Repeated 
several 
times  
  Comparative study between a 3-D and a 2-D 
culture system highlighted the increase in 
the number of hASCs to upto 10 fold in the 
former against 2-8 fold expansion in the 
latter experiments. These hASCs retained 
their capability to differentiate into 
adipogenic, osteogenic and chondrogenic 
lineages as they positively expressed surface 
markers of pluripotency viz. Oct-4, Sox-2 
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during 3-D culture. 
 
31 Human 
Adipose 
tissue ECM 
(4–5 times) 
freeze-thaw 
digested in 
0.5 M acetic 
acid 
Solvent: 
1,1,1,3,3
,3-
hexaﬂou
ro-2-
propano
l or 
2,2,2-
triﬂouro
acetic 
acid  
650RP
M 
2.5 
mL/hr. 
+25 kV 
 
Digested  tissue 
dialyzed 
Lyophilized 
 
Scaffold cross-
linking for 72 hr at 
RT in 30 mM 
genipin 
The attachment and growth of ASC on 
electrospun At-ECM with similar results 
under blended scaffold with polydioxanone, 
suggesting that cultivation of ASC is higher 
in electrospun At-ECM scaffolds. The 
results of these studies validate the 
credibility of At-ECM scaffolds which can 
be isolated and electrospun as a basement 
membrane-rich matrix which can support 
stem cells. These results pave way for 
further future regenerative medicine studies. 
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32 Human 
Adipose 
tissue ECM 
Mechanical 
disruption, 
polar 
solvent 
extraction 
inisopropan
ol, and 
enzymatic 
digestion 
(trypsin/ED
TA, DNase, 
RNase, and 
lipase). 
 Decontaminated, 
digested with 
mixture of acetic 
acid/pepsin 
Microcarrier fabrication methods were 
developed from decellularized adipose tissue 
(DAT) through non cytotoxic protocols. The 
efficacy of the fabrication protocols to 
produce stable beads as well as that of 
microporous surface topography was 
confirmed through microscopic 
characterization.  
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33 PLGA 
Type I 
collagen 
Porcine ECM 
from the  SIS 
and UBS  
composite of 
PLGA and 
UBS 
Washing, 
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment, 
 lyophilized UBS-
ECM powder was 
uniformly mixed 
with PLGA to create 
produce composite.  
Sites implanted with porcine ECM as 
compared to sites implanted to either Type I 
collagen or PLGA showed larger number of 
cells expressing Gpi-1. Recipient mice 
transplanted with marrow cells expressing β-
galactosidase validated that majority of the 
population of cells which remodelled the 
naturally occurring porcine ECM were 
marrow derived. A significant increase in 
the number of marrow-derived cells which 
integrated into remodelled implant site were 
as a result of addition of porcine ECM to the 
PLGA scaffold. 
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34 Decellularize
d porcine 
dermis 
Series of 
agitations 
involving 
organic 
solvents, 
detergents, 
salt 
solutions, 
enzymes 
and multiple 
rinsings. 
 Lyophilization,  
ethylene oxide 
sterilization. g. 
In the post-processing examination it was 
found that various ECM proteins such as 
collagen III, collagen IV, collagen VII, 
laminin and fibronectin remained in the 
material. Glycosaminoglycans such as 
hyaluronic acid were also found to be 
present. Examination and quantification for 
the presence of cytokines showed more 
vascular endothelial growth factor (VEGF) 
and transforming growth factor b (TGF-b) as 
compared to decellularized dermis materials. 
Bioactivity retention was also demonstrated 
via cell culture assays. 
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35 Porcine 
UBM. 
Delaminatio
n, peracetic 
acid/ 
ethanol 
treatment, 
 Powderisation:  
1.The snap frozen 
material ,  reduced to 
small pieces  
2. Salt (NaCl) 
mediated snap 
freezing and 
chopping  Waring 
blender 
 
Ground particles without salt precipitation 
when observed under SEM were found to be 
irregularly shaped sheet-like structured. The 
ones produced by salt precipitation method 
were found to be round and porous in 
appearance with a particle size range of 
1mm which agglomerates with each other 
and bigger particles. It was concluded that 
the production of ECM particles of a 
uniform particle size depends on the 
manufacturing methodology 
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36 Porcine SIS, 
UBM, Liver  
SIS & 
UBM: 
delaminatio
n, peracetic 
acid/ 
ethanol 
treatment, 
Liver 
stroma: 
trypsin, 
EDTA,  
Triton X-
100, sodium 
deoxycholic 
acid, 
peracetic 
acid 
treatment.  
 -- The remaining DNA was shown to be 
present in smaller fragments according to the 
study, indicative of low possibility of these 
fragments playing a causative role in any of 
the adverse tissue remodelling response 
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3. MATERIALS AND METHODS 
3.1. Procurement of Adipose Tissue 
Human subcutaneous adipose tissues were harvested from patients undertaking during 
reduction mammoplasty or abdominoplasty procedures at the Seva clinic, Kolkata, India. 
Upon collecting the tissue, were stored in sterile plastic bags and stored at 4ºC and 
transported to to lab.  
3.2. Decellularization of Adipose Tissue 
 The Cauterized portions parts of the harvested adipose tissue were discarded and the 
tissue washed in distilled water for 3-4 times to remove the blood components. The washed 
adipose tisuue mixed with double volume of distilled water and homogenized in house hold 
blender for 5min with pulsation in every 30 seconds. The oil expelled out from the cells 
during homogenization was separated by centrifuging the suspension at 3000g for 5 min at 
room temperature. The upper oil layer and lower water rich layer discarded and the middle 
layer containing adipose tissue and ECM stored for further processing. The sample after 
mechanical decellularization (homogenization), treated with freeze thawing method. The 
sample subjected to 15 cycles of freeze thawing (-20⁰C- 37⁰C), oil expelled after each cycles 
was removed by centrifugation at 3,000g for 5 min. After the freeze-thawing the samples 
were treated with anionic detergent sodium dodecyl sulfate (SDS) to remove the oil content 
and also help to break the plasma membrane and nuclear membrane thus will help to remove 
the immunogenic component DNA. The ECM stirred in 0.5% SDS solution for 1h at room 
temperature. The SDS trapped inside the ECM was removed by continuous washing in 
distilled water for 24h at 4⁰C with a water replacement in 2hr gap. The SDS treated ECM 
were fabricated in to three dimensional scaffold by freeze drying method.  
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3.3. Evaluation of decellularization and delipidization 
The extent of decellularization can be visualized by hematoxylin and eosin (H&E) 
staining.  The tissue and decllularized tissue were fixed in paraformaldehyde and embedded 
in paraffin wax and sectioned in to 20 µm slices and the slides used for histological analysis. 
The procedure for H&E staining as follows.  
 Flushed with hematoxylin for 10min 
 Washed in running tap water for 5min 
 Treated with acid-alcohol (1ml HCl + 49ml 70% ethanol) solution for 30s 
 Washed in running tap water for 1min 
 Blushed in ammonia water(0.2%) for 1min 
 Washed in running tap water for 5 min 
 Rinsed in 95% ethanol (10 dips) 
 Counter stained the tissue with Eosin (1-5min) 
 Washed in running tap water 
 100% ethanol treatment for 1 min  
 Xylene: 100% ethanol treatment for 1 min  
 Xylene treatment for 1 min  
 Observed under simple microscope   
The delipidization efficiency compared after each step of decellularization with Scanning 
Electron Microscopy SEM (JEOL JSM 6480LV SEM) analysis. The oil content in the ECM 
affects surface characteristics of lyophilized ECM that analyzed from SEM images.  
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3.4. Freeze drying of decellularized tissue 
The decllularized tissue frozen at -80⁰C for 24hr and were lyophilized in a freeze-
dryer (Operon Chemical free freeze dryer-120C) under -115⁰C and 650-950mmtorr for at 
least 48 hr.Scaffolds were then cross linked by UV (λ=254nm) irradiation for 15min and 
stored in air tight container. 
3.5. Characterization of porous ECM scaffold 
3.5.1. Scanning electron microscopy: 
The morphology of obtained scaffolds was observed at both cross-section and 
longitude-section using SEM (JEOL JSM 6480LV SEM) after being coated with platinum 
powder at an acceleratingvoltage of 15 kV. 
3.5.2. Fourier Transform Infra-Red (FTIR) spectroscopy: 
The chemical functional groups were analyzed by Fourier transform infrared 
spectroscopy (FTIR, BRUKER) in the range of 500 – 3500 cm− 1. ECM Samples were milled 
with potassium bromide KBr and pressed into pellets before the FTIR analysis.  
3.5.3.Visualization of elastic fibers by staining (Verhoeff-Von Gieson staining): 
The sections of ECM after decellularization were stained to detect the presence of 
elastic fibers. The sections were ﬁrst stained with Verhoeff‘s hematoxylin                                                                                                   
for 30 min. Samples were washed with distilled water and differentiated in 2% ferric chloride 
(FeCl2) solution and observed under microscope for black fibers on gray background. 
Samples were washed again with water and treated with 5% hypo for 2 min to remove the 
iodine after decolorization washed again and counter stained with Van Gieson‘s for 5min. 
stained sections were dehydrated and examined microscopically for black elastic fibers and 
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red collagen fibers.  
3.5.4. Swelling Ratio study  
Swelling ratio indicates the affinity of scaffold to hold the water in its matrix that is 
proportional to hydrophilicity of scaffold. ECM scaffolds after lyophilization were weighed 
(Wd) and immersed in phosphate buffered saline PBS (, pH 7.4) at room temperature. The 
scaffolds  were  removed from PBS  and  blotted  on  ﬁlter  paper to  remove  loosely bound  
water  and  wet  weights  of  the  scaffolds (Wt) were noted  after a particular period of time 
(5, 10, 20, 30, 60, 120 min). The experiment was performed in triplicates. The swelling ratio 
(%) can be deﬁned as the ratio of the weight increase (Wt − Wd) to the initial dry weight (Wd 
).                                               Swelling ratio (%) = 
     
  
  % 
3.5.5. Biodegradability  
Acellular ECM scaffolds were weighed (30±5mg) and then immersed in 10 ml 
autoclaved PBS containing 0.7U/ml collagenase IV (MP Biomedicals 195110) and incubated 
at 37°C with a gentle shaking. At fixed time intervals, scaffolds were removed from PBS, 
rinsed with water, lyophilized and weighed to measure the weight loss. The biodegradability 
can be calculated by using the equation: 
                                     Biodegradability (%) = 
     
  
  % 
Where Wi is the initial weight and Wf is the weight after incubation time t.  
3.6. Development of nHA by wet chemical method 
The nHA was prepared by wet chemical method using Calcium nitrate 
Ca(NO3)2·4H2O and Ammonium phosphate dibasic (NH4)2HPO4 as Ca and P precursors, 
respectively. 
10Ca (NO3)2 + 6(NH4)2HPO4 + 8NH4OH → Ca10 (PO4)6(OH)2 + 20NH4NO3 + 6H2O 
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0.03 M aqueous solution of Ammonium phosphate dibasic was added drop wise to 0.05 M 
aqueous solution of calcium nitrate with vigorous stirring at 80±5 °C. The pH of calcium 
nitrate solution used for the reaction was adjusted to 11-12 with ammonia (NH4OH). The 
nano HA (nHA) particles aged for overnight at room temperature. The sediment nHA 
particles were collected and washed with distilled water and harvested by centrifuging at 
8000g for 10min. The powder dehydrated by freeze drying and calcinated to make it more 
crystalline at 600 °C for 1 h. (Fig 2)  
3.6. Characterization of nHAP 
3.6.1. X ray diffraction  
The qualitative phase content of produced nHA were analyzed by  by X-ray 
diffraction (XRD) by using a XRD diffractometer (X‘Pert MPD Philips analyticl PANalytical 
1.57A) with filtered 0.154056 nm Cu Kα radiation, in the scanning range 2θ = 0 – 70o.The 
results obtained from the machine analyzed with X‘Pert HighScore software package and 
identified the presence of characteristic peaks of nHA and crystal size also estimated.  
3.6.2. FTIR Spectroscopy  
Different functional groups present in the prepared nHA powder were studied with 
Fourier transform infrared spectroscopy FTIR by using FTIR-BRUKER Spectrometer. Prior 
to scanning nHA mixed with KBr powder (1:99) and pressed to 10mm diameter discs. The 
nHA disc were scanned in the range of 400-4000 cm-1. 
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Fig 2: Schematic flow chart for the synthesis of nHA 
 
 
0.05 M aqueous solution 
of Ca(NO3)2·4H2O Ammonia NH4OH 
Add Drop wise 
Vigorous stirring at 80-
90⁰C 
 
Centrifugation 8000g for 
10min 
 
Powderwas frozen at−20 
°C for 1 h 
Dried in freeze dryer at 
−160 °C for 2days 
Calcined at 600 °C for 1 h. 
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3.6.3. Scanning electron microscopy (SEM) and EDS. 
The approximate particle size can be measured from SEM images. nHA powder 
spread on carbon tape and observed in JEOL JSM 6480LV-type scanning electron 
microscope (SEM), operating at 25kV in vacuum. The energy dispersive X-ray attachment 
(EDAX/2001 device) attached to the SEM system can be used for elemental analysis of the 
powder.  
3.6.4. Quasi-elastic light scattering (QELS) / Dynamic Light Scattering (DLS). 
The size distribution profiles of nHA particles in suspension were studied using a 
Dynamic Light Scattering DLS (Zeta Sizer nano analyser Malvern). Before measuring 
particle size distribution, the suspensions (in water or 70% ethanol) were ultrasonicated the 
with a probe ultrasonicator. 
3.7. ECM-nHAP Composite scaffold fabrication & Characterization 
The ECM-nHA composites were synthesized using by adding the nHA particles to the 
digested ECM solution prior to lyophilisation (suspension method). ECM digested by stirring 
the matrix with 0.5M acetic acid (1:2) for 2 days. In the suspension method, nHA particles 
suspended in water were added into the digested ECM solution during the blending stage, 
followed by lyophilisation. Composite scaffolds containing 50 and 70% nHA prepared and 
characterized by XRD, FTIR, SEM and Mechanical Strength analyzer. 
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4. RESULTS AND DISUCSSION: 
4.1. Decellularization 
The adipose tissue harvested was red in color because of the presence of blood, and 
the presence of lipid-filled adipocytes makes the tissue oily and viscous. After 
decellularization the ECM become whitish and highly hydrated.  
 
Fig 3: Red (Left): Adipose tissue before decellularization White (Right): Adipose tissue after 
decellularization 
Blending procedure were found to be very effective decellularization method, because a large 
quantity of oil released after blending Fig: 4  
 
Fig 4: Oil separated after blending and subsequent centrifugation  
 
52 
 
4.2. Evaluation of decellularization and delipidization 
H&E Staining: 
 
Fig 5: H&E Staining of Adipose tissue (right) and decllularized tissue (left) 
H & E staining of tissue samples shown closed compartments these are adipose cells. 
But the H & E staining of decllularized matrix does not shown closed compartments, i.e. 
cells.  H& E staining conﬁrmed the absence of cells and cell debris in the decllularized 
(Fig.5) 
SEM analysis: 
The SEM analysis of Scaffold obtained after different stages of decellularization are 
shown below (Fig:6).  
ECM surface after simple homogenization is an uneven globular appearance 
indicative of high lipid content. But the repeated freeze is thawing and SDS washing removed 
the lipid content. 
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Fig.6. SEM results of ECM at different stages of decellularization process. 
 
4.3. Freeze drying  
After freeze drying a soft porous ECM scaffolds of different dimensions were obtained as 
shown in Fig: 7 
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Figure 7: Porous Scaffold after freeze drying  
4.4. Characterization of ECM scaffold  
4.4.1. Simple Microscopy 
The scaffold shown highly porous structure, approximately 100-200µm pores were 
visible under the microscope (Fig.8)  
 
Fig 8: Light Microscopy of ECM Scaffold stained with eosin at 4X magnification 
4.4.2. Scanning Electron Microscopy  
Fig -9, 10 shows the SEM images of porous ECM scaffolds prepared from freeze 
drying method. The scaffold found to be highly porous and have interconnected pores also. 
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Figure 9: ECM Scaffold: Transverse cross section 
 
Figure 10: ECM Scaffold: Longitudinal section 
From the SEM image it was observed that average pore size of ECM was 257 µm and pores 
were well interconnected. 
4.4.3 Fourier Transform Infra-Red (FTIR) spectroscopy: 
Characteristic wavenumber of following protein (Collagen) functional groups were found  
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Figure 11: FTIR Result of ECM Scaffold 
Table 5: ECM Functional groups and their wave number  
Sl 
No: 
Functional group Wave number 
(cm
-1
) 
1 Amide  I region:  mainly C=O  , C-N bonds  1585-1720 
2 Amide  II region: mainly combination  of    C-N stretching and N- H 
bending vibrations 
1500-1585 
3 Amide  III  region: mainly C-N stretching,  N-H bending, C-C 
stretching, and sulfate stretching vibrations 
1200-1300 
4 CH2  bending  vibrations,  CH3  asymmetric  bending  vibrations,  
COO
-
 stretching  vibrations,  and  CH2  side  chains vibrations  of  
collagen 
1300 1500 
5 CH2  side  chains  vibration 1340 
6 Carbohydrate region: stretching vibrations of  
C-O  and  C-OH,  as  well  C-C  ring vibrations 
985-1140 
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4.4.4. Visualization of elastic fibers by staining (Verhoeff-Von Gieson staining): 
The sample is stained with a regressive hematoxylin, consisting of ferric chloride and 
iodine. The differentiating is accomplished by using excess mordant (ferric chloride) to break 
the tissue-mordant dye complex. The dye will be attracted to the larger amount of mordant in 
the differentiating solution and will be removed from the tissue. The elastic tissue has the 
strongest affinity of the iron-hematoxylin complex and will retain the dye longer than the 
other tissue elements. 
 
 
Fig: 12: elastic fibers by staining (Verhoeff-Von Gieson staining) 
The ECM sections are rich in collagen (Red fibers) and elastic fibers (Black fibers) 
even after decellularization. It indicates that the decellularization method which we used did 
not affect the elastic protein much.  
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4.4.5. Swelling ratio 
To  determine  the  water  retention  or  uptake  property  of  the  scaffolds  which  is  
one  of  the  important  properties  required  for  scaffolds to  be  used  in  bone  tissue  
engineering,  the  scaffolds  were  subjected for  swelling  studies  as  described  in  Section  
2.4.3.  
Table: 6: Swelling ratio data of ECM Scaffold  
Sl 
No 
Time (min) Weight (g) Swelling Ratio  
1 0 0.0758 0 
2 5 0.1149 0.5158 
3 10 0.138 0.8206 
4 20 0.2245 1.9617 
5 30 0.321 3.2348 
6 60 0.4008 4.2876 
7 120 0.4153 4.4789 
8 240 0.4164 4.4934 
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Figure 13: Swelling study of ECM scaffold 
The swelling study indicated that the swelling ratio increased rapidly in first 1hr, after 
1hr it was found to be almost constant value of approximately 430%.  The increase in 
swelling ratio indicates that the increase in pore diameter and will help in easy cell 
infiltration. 
4.4.6. Biodegradability: 
Table 7:  Biodegradability data of ECM Scaffold 
Sl No No: days of incubation Weight loss in % 
PBS Collagenase + PBS 
1 1 1.7 12.6 
2 3 2.5 13.5 
3 7 3.8 14.7 
4 9 5 15.2 
5 12 6.8 16.8 
6 21 12.3 24.3 
7 24 13.7 27.8 
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Figure 14: PBS and enzyme Biodegradation of ECM scaffold 
From the graph it is clear that the ECM scaffolds are biodegradable in PBS also. The 
addition of enzyme collagenase increases the degradation rate; it indicates that the scaffold is 
rich in collagen molecules.  
Fig. 15 shows SEM micrographs of various scaffolds after 21 days of incubation in PBS. 
From the images it‘s clear that the pores get degraded by enzyme collagenase is more 
effective than PBS. It indicates that the scaffold mainly contain collagen protein. 
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Fig: 15 SEM images of PBS (left) and Collagenase (Right) degraded scaffolds/ 
4.5: Nano Hydroxyapatite nHA- characterization  
4.5.1:  XRD Result  
Figure 16 shows the XRD patterns of the nHA powders. Characteristic peaks of nHA 
(2Ө = 25.76°, 28.16°, 31.86°, 40.04°) were found in the spectrum by X‘Pert Highscore 
software.All peaks were corresponding to hydroxy apatite and no additional peaks were 
found. The result indicates that the synthesized HA powder was phase pure. 
Nanoparticle crystal size can be estimated by the following equation: 
 
 
λ : Wavelength of X ray used ( 1.54A⁰ ) 
β: Wavelength of the full width at half maximum (FWHM=0.7872) 
Ө: theta value correspond to maximum intensity peak (15.8421) 
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Figure 16 : XRD Result of nano hydroxy apatite  
4.5.2. FTIR  
Figure 17:  shows FTIR spectra of the nHA. The wave number of bands and their 
assignments are summarized in Table.  
Table 8: Characteristic wave number of powder HA 
Sl 
No: 
Functional group Wave number (cm-1) 
1 ν2 (PO4
3-
) 470 
2 ν4 (PO4
3-
) 550, 600 
3 ν1(PO4
3-
) 960 
4 ν3(PO4
3-
) 1040, 1100 
5 νL (OH
-
) 632 
6 ν3(OH
-
) 3572 
7 ν2(CO3
2-
) 860 
8 ν3(CO3
2-
) 1470 
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9 ν (NO3
2-
) 1400 
10 ν(OH-) adsorbed water 1640, 3450 
 
 
Fig: 17: FTIR Spectrum of nHA 
4.5.3 Dynamic Light Scattering (DLS) 
The size distribution profile of nHA particles in suspension is shown in Fig: 18, the 
single peak in the data indicates that all aggregate are of same range. The average size of the 
aggregates in the water suspension is 902nm.   
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Fig: 18: Dynamic Light Scattering Result of nHA 
4.5.4. SEM-EDS of nHA 
The SEM analysis of nHA powder is shown in Fig: 19, from the SEM it is clear that 
the particles are very small (did not go for more magnification because of machine disability)  
 
Fig: 19 SEM result of nHA 
 
Fig: 20 : EDS of nHA 
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The EDS results (Fig: 20) shown that the compound produced possess all the elements of HA 
(Ca10 (PO4)6(OH)2) like Ca, P, N,O. the presence of Carbon might be an impurity developed 
during the synthesis.  
4.6: ECM-nHA composite scaffold characterization  
ECM-nHA composite scaffolds were successfully synthesized by using the 
suspension method as shown in Fig: 21 
 
Fig: 21: ECM-nHAP composite scaffolds (70%nHA Scaffold) 
 
The scaffold containing 50% nHA shows more strength than simple ECM scaffold, but its 
very weak whrn it compare with scaffold having 70% nHA.  
4.6.1. SEM:  
ECM 50%nHA: Composite scaffold containing 50% nHA gave porous structure with average 
pore size  110 µm but from images its cleat that scaffold is not strong enough looks like puffy 
scaffold.(Fig:22)   
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Fig: 22: SEM composite scaffold (50% nHA) 
 
ECM 70%:ECM scaffold with 70% shown highly porous structure with an average pore size 
of 170 µm which is suitable for bone tissue engineering. 
 
  
Fig: 23: SEM composite scaffold (70% nHA) 
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4.6.2. FTIR:  
 
FTIR analysis of composite scaffold showed the characteristic peaks of both nHA and ECM.  
 
Fig: 24: FTIR composite scaffold (70% nHA) 
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4.5.1. XRD Results  
The XRD results of composite shown all characteristics peaks of nHAP, it indicates 
that nHAP incorporated properly in the scaffold. (Fig: 25)  
 
Fig: 25: XRD- ECM, nHA and composite scaffold (70% nHA) 
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5. CONCLUSIONS AND FUTURE PLANS: 
 
 In the current study optimized a Decellularization process by homogenization, freeze 
thawing & SDS treatment. The freeze drying of decellularized tissue gives a highly porous 
and hydrophilic scaffold which is suitable for soft tissue engineering. We can develop 
hydroxyapatite nano particles of 10nm size by simple wet chemical method which is suitable 
for bone tissue engineering. The composite scaffold developed by suspension method with 
acetic acid digested ECM showed good porous structure and mechanical strength which is 
desirable for bone regeneration applications. 
In future we are planning to perform following ideas: 
 Optimization of Composite scaffold fabrication for bone tissue applications  
 In- vitro expansion of human adipose -derived stem cells in the developed scaffolds 
 In- vivo study of the fabricated scaffold in animal model. 
 Clinical trial experiments  
 Marketing the product  
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